Purpose: To compare the outcomes of microcatheter-assisted circumferential trabeculotomy to standard rigid probe trabeculotomy in childhood glaucomas. Methods: Eyes of children requiring trabeculotomy for primary congenital or secondary paediatric glaucoma were randomized to undergo either trabeculotomy using the Glaucolight illuminated microcatheter, or a rigid probe trabeculotomy. Complete success was defined as an intraocular pressure (IOP) of <18 mmHg without medications. Results: A total of 62 eyes of 62 patients were included. Of these 30 eyes of 30 patients aged 5.6 AE 4.8 months underwent microcatheter-assisted trabeculotomy, with 15 eyes (50%) having a complete 360°cut, while 15 eyes (50%) had an incomplete cut ranging from 250 to 350 degrees. The rigid probe trabeculotomy group included 32 eyes of 32 patients aged 4.4 AE 3.8 months. At the end of the 2-year follow-up period, the complete success and the failure rates were 67% and 15%, respectively, in the microcatheter-assisted group versus 47% and 50% in the rigid probe trabeculotomy group (p = 0.006). There was a tendency towards lower IOP in the microcatheter group at 1, 3, 6, 12 and 24 months postoperatively, with the difference in IOP reaching statistical significance at 6 months (p = 0.004). The mean survival time was significantly longer for the microcatheter group (p = 0.01). Conclusion: At 2 years postoperatively, microcatheter-assisted trabeculotomy still yielded superior results in terms of IOP control and success rates in children with primary congenital glaucoma. The need for reoperation for glaucoma was significantly lower in the microcatheter group.
Introduction
Trabeculotomy is an ab-externo angle surgery performed in children with glaucoma in whom goniotomy has failed or is expected to fail due to advanced disease, or in cases where a gonioscopic view is not possible due to corneal cloudiness (Luntz 1979 ). The success rates of traditional trabeculotomy in primary congenital glaucoma have varied from 73% to over 90% (Beck & Lynch 1995; Al-Hazmi et al. 2005; Yalvac et al. 2007) ; with the introduction of 360°trabeculotomy using a 6-0 suture, the success rates reported ranged from 87% to 93% (Medicino et al. 2000; Verner-Cole et al. 2006) . The main disadvantage of 360°suture trabeculotomy is the potential risk of false passages with some cases reported to result in inadvertent misdirection into the suprachoroidal and subretinal spaces (Neely 2005; Verner-Cole et al. 2006) . Trabeculotomy with an illuminated microcatheter has recently emerged as a possible first-line procedure in the management of glaucoma in children. In 2010, Sarkisian reported on the results of performing 360°trabeculo-tomy in primary congenital glaucoma using an illuminated flexible microcatheter (iTRACK 250A; iScience Interventional, Menlo Park, CA, USA; Sarkisian 2010) allowing continuous visualization of the catheter inside Schlemm's canal. In his retrospective case series on 16 eyes, there were no cases of microcatheter misdirection and the IOP reduction at 6 months was 46%. Other studies have reported an 83-91% success rate of circumferential trabeculotomy after a follow-up period of 6 months to 1 year (Girkin et al. 2012a,b; Lim et al. 2015; Shi et al. 2015; Temkar et al. 2015) .
We report the 2-year results of our prospective study on 360°trabeculo-tomy using an illuminated microcatheter in the treatment of primary congenital glaucoma.
Materials and Methods
This was a prospective interventional randomized study conducted on children under the age of 10 years who required a trabeculotomy for primary congenital glaucoma. In the Microcatheter-assisted group, a 360°trabecu-lotomy was attempted using the Glaucolight illuminated microcatheter (DORC International, Zuidland, the Netherlands). The Glaucolight is a lightfibre-based device with an atraumatic tip-design that has an external diameter of 150 microns (40 Gauge). The device has an integrated (battery powered) LED source that illuminates the fibre tip, allowing visualization of the position of the fibre throughout Schlemm's canal passage. The rigid probe trabeculotomy group was a control group of eyes that had traditional trabeculotomy using Harms trabeculotomes. Exclusion criteria were eyes that underwent previous surgery, eyes requiring combined procedures and eyes in which the trabeculotomy involved ≤120°of Schlemm's canal. Patients were randomized to undergo 360°trabeculotomy or standard trabeculotomy using a random table. In patients requiring bilateral trabeculotomy, only one eye -the higher IOP eye -was included in the study.
Sample size calculation
An estimation of sample size was performed considering a study power of at least 0.8 with an alpha error of 0.05 aiming to detect a difference of 4 mmHg in mean IOP in the postoperative month 24 between the two groups, assuming a standard deviation of 5 mmHg. Based on this estimation, a total of 52 eyes were found to be adequate, and considering a total of 20% dropout during the follow-up, recruitment of at least 62 study subjects was targeted.
Demographic data included age at which symptoms appeared, age at surgery, gender, consanguinity, family history of paediatric glaucoma and laterality of glaucoma. Preoperative and postoperative examination included number of glaucoma medications, intraocular pressure measured by Perkins or Goldmann tonometer, corneal diameter, slit lamp and fundus examination. Ocular ultrasonography was performed when needed. In younger children in whom examination was difficult, chloral hydrate sedation was used. Any postoperative complication or intervention was noted.
The study was approved by Cairo University research ethics committee and followed the tenets of the Declaration of Helsinki.
Surgical technique
An informed consent was obtained from the patients' parents. All surgeries were performed by one of two surgeons (GG, YE).
In the 360°trabeculotomy group, a conjunctival peritomy was followed by the creation of a rectangular scleral flap in the inferotemporal quadrant. Schlemm's canal was located, cannulated by a trabeculotome, and 2 mm of the canal was deroofed using a superblade. Sodium hyaluronate (Hyaluron-Visc, Dorc, the Netherlands) was injected into each cut end of the canal to dilate it. The microcatheter was then inserted through one of the cut ends and threaded circumferentially throughout the canal until coming out of the opposite cut end. The two exposed ends of the microcatheter were then grasped and pulled in opposite direction, thus incising Schlemm's canal over 360°. In cases where the microcatheter reached an obstruction or became misdirected, the conjunctiva was dissected and a scleral cut down was created over the illuminated tip of the microcatheter. The catheter was then grasped and its two ends pulled, partially incising Schlemm's canal. Trabeculotomy was then attempted by a trabeculotome in the other ends of Schlemm's canal under the dissected scleral flaps. A paracentesis was created whenever needed to allow anterior chamber reformation by sodium hyaluronate or to wash any significant hyphema. At the end of the procedure, the scleral flap and conjunctiva were closed by 10/0 nylon sutures followed by subconjunctival injection of antibiotic and steroid.
The technique for standard trabeculotomy has been well described before. In brief, after identification of Schlemm's canal under an inferotemporal scleral flap, the Harms trabeculotome (Geuder, Heidelberg, Germany) was inserted into the canal and swept into the anterior chamber tearing the trabecular meshwork and inner wall of Schlemm's canal over 70°-90°on each side.
Postoperatively patients were given topical tobramycin/dexamethasone combination four times daily tapered over 2-4 weeks. Patients were generally seen on day 1, weekly for a month, monthly for 6 months, then every 3-4 months. More frequent visits were required in cases with complications or inadequate IOP control. Antiglaucoma medications were added for patients with IOP ≥18 mmHg or for those with signs of glaucoma progression (increasing corneal diameter, or cup-todisc ratio). A topical beta-blocker (timolol 0.5%) was prescribed first. This was replaced by a fixed combination of beta-blocker and carbonic anhydrase inhibitor (dorzolamide 2% -timolol Complete success was defined as IOP of <18 mmHg with no other signs of glaucoma progression (increasing corneal diameter, axial length or cupto-disc ratio). The use of glaucoma medications to achieve such a pressure was considered as qualified success and failure was considered if no such pressure could be achieved despite maximum tolerated medical treatment, or if a subsequent glaucoma procedure was needed to control the IOP or if a devastating complication occurred (e.g. retinal detachment, endophthalmitis or suprachoroidal haemorrhage). Eyes that underwent a second glaucoma procedure were excluded from the analysis subsequent to the intervention.
Statistical analysis
Statistical analysis was performed with SPSS for Windows version 15.0.1 (SPSS Inc., Chicago, IL, USA). Demographic data and preoperative data for both groups were analysed with independent t-test or Fischer's exact test. Intraocular pressure comparisons between the two groups were analysed with independent t-test. Rates of surgical success were analysed by Fischer's exact test. Kaplan-Meier survival analysis for success was calculated with the log rank test. Mean survival times with 95% confidence intervals (CIs) were reported.
Results
Thirty-two eyes of 32 patients were enrolled in each group. In the microcatheter-assisted trabeculotomy group, two eyes were excluded from the analysis as a trabeculotomy of >120 degrees could not be achieved. For the remaining 30 eyes, trabeculotomy was performed over 250-350°of the angle (mean 323 AE 42°), with 15 eyes (50%) having a complete 360°cut. Table 1 shows the demographic features of both groups. There was no significant difference in gender, laterality, age at surgery or age at presentation. There was also no significant difference in preoperative intraocular pressure, number of eyes with cloudy corneas or number of preoperative glaucoma medications.
Intraocular pressure (IOP)
Table 2 compares the intraocular pressure in both groups preoperatively, at 1 month, 3 months, 6 months, 1 year and 2 years. There was a significant reduction in intraocular pressure in both groups and throughout all the postoperative follow-ups. There was a tendency for a lower intraocular pressure in the microcatheter-assisted trabeculotomy group at all postoperative follow-ups.
The difference was statistically significant at 6 months postoperatively (p = 0.04).
Number of glaucoma medications
Although there was a tendency for a lower number of medications in the microcatheter group at all postoperative follow-ups, the difference did not reach statistical significance. Table 2 shows the number of medications at different time-points.
Change in cup-to-disc ratio
In eyes in which the optic nerve head was seen preoperatively, six of 15 eyes (40%) showed reduction in cupping by at least 0.2 in the microcatheter group compared to four of 15 eyes (27%) in the rigid probe trabeculotomy group. 
Success rates
Figure 1 is a flow chart showing success rates at the different follow-ups. At the end of the 2-year follow-up, 18 of 27 eyes (67%) of the microcatheter group were classified as complete success, and four (15%) as failures. Three of the failures were because of undergoing a subsequent glaucoma operation while one eye had late postoperative endophthalmitis. In the rigid probe trabeculotomy group, 14 of 30 eyes (47%) were classified as having complete success, and 15 (50%) were classified as failures either because of the need for a subsequent glaucoma operation (13 eyes) or because the IOP was more than 18 mmHg on medications (two eyes). There was a statistically significant difference in failure rates between both groups (p-value = 0.006). Kaplan-Meier survival analysis was performed to compare the survival rates between the two treatment groups (Fig. 2) . The cumulative probability of survival by the log rank test at the end of the second year was 76.7% in the microcatheter trabeculotomy group and 43.8% in the conventional trabeculotomy group.
The mean survival time was significantly longer (p = 0.01, stratified log rank test) for the microcatheter-assisted group (19.30 months (standard error 1.59), 95% confidence interval (CI) 16.18-22.42 months) than for the rigid probe trabeculotomy group (12.41 months (standard error 1.84), 95% CI 8.79-18.29 months).
Subsequent glaucoma procedures
Three eyes (10%) in the microcatheter group required repeat glaucoma surgery in the form of trabeculectomy, compared to 13 eyes (41%) in the conventional trabeculotomy group. Of the 13 eyes, one had trabeculectomy and the rest underwent repeat trabeculotomy 180°away from the site of the original trabeculotomy. The difference in the number of postoperative glaucoma operations was highly statistically significant (pvalue = 0.008).
Eyes that underwent subsequent trabeculectomy in the microcatheter group had the operation 4-7 months after the initial trabeculotomy (mean 5.1 AE 1.7), while in the conventional trabeculotomy group, surgeries were performed at 3-9 months postoperatively (mean 5.6 AE 1.8). The mean IOP before reoperation was 23.6 AE 3.9 mmHg in the microcatheter group and 27.2 AE 3.1 in the rigid probe trabeculotomy group. There was no significant difference between both groups (p = 0.2).
Of the 12 eyes that underwent a repeat trabeculotomy, three (25%) were classified as failures as they required a subsequent trabeculectomy at 3-12 months, while six eyes (50%) were classified as complete success after 11.8 AE 6.7 months of follow-up.
Postoperative complications
In the microcatheter group, three eyes developed postoperative shallowing of the anterior chamber that resolved spontaneously with no sequelae and two eyes had a self-limiting hyphema (>25% of the anterior chamber) on the first postoperative day. One eye developed endophthalmitis at 1 year and one eye developed cataract at 2 years.
In the rigid probe trabeculotomy group, one eye developed postoperative shallowing of the anterior chamber and two eyes had postoperative hyphema. None required any intervention.
Subgroup analysis
The microcatheter-assisted trabeculotomy eyes were further classified according to the extent of trabeculotomy into complete 360°trabeculotomy (15 eyes) and incomplete, <360°tra-beculotomy groups (15 eyes). In the incomplete subgroup, the extent of trabeculotomy ranged from 250 to 350 degrees (mean 323 AE 42°). (p = 0.006), the postoperative IOP was not significantly different among both subgroups at any time-point. There was no significant difference in success rates or survival times between both subgroups either (p = 0.2 and 0.5, respectively).
Discussion
Sarkisian was the first to report the results of trabeculotomy using an illuminated microcatheter in congenital glaucoma demonstrating a 47% reduction in IOP at 6 months (Sarkisian 2010) . Other authors have compared the procedure to different glaucoma surgeries in children (Girkin et al. 2012b; Lim et al. 2015; Shi et al. 2015; Temkar et al. 2015) . Table 3 presents the results of studies on microcatheter-assisted trabeculotomy in both primary and secondary paediatric glaucoma and compares them to the current study.
Our study showed that, up to 2 years postoperatively, eyes that underwent microcatheter-assisted trabeculotomy continued to have a lower IOP and required fewer glaucoma medications than those that underwent a conventional rigid probe trabeculotomy. The difference in IOP was statistically significant at 6 months. The difference in failure rates at 2 years was significantly lower in the microcatheter group, with less eyes requiring subsequent glaucoma procedures (p = 0.006). Kaplan-Meier survival analysis showed significantly longer survival time for the microcatheter-assisted group (p = 0.01).
The success rates of trabeculotomy vary from 73% to more than 90% with one or more trabeculotomies (Beck & Lynch 1995; Yalvac et al. 2007) , and AlHazmi et al. (2005) reported that the success rates of trabeculotomy in their retrospective study have increased from 29% to 82% over the 20-year study period. This may suggest that in some cases, the rigid trabeculotome may be misdirected after entry into Schlemm's canal or that Schlemm's canal may be missed from the start. Allowing direct visual verification of the illuminated tip as it passes circumferentially around the limbus allows continuous assurance of proper placement. Retrieving the microcatheter tip from the opposite end of Schlemm's canal after having passed 360°around the limbus is the only sure sign that it remained inside Schlemm's canal throughout its path, and we postulate that the higher success rate of 360°t rabeculotomy may be partly related to this reason. It is also possible that the bigger extent of the cut yields superior results, yet our subgroup analysis in the microcatheter group showed no superiority of IOP lowering or success rates in eyes that had complete 360°trabeculo-tomy versus those with partial 250-350°t rabeculotomy. Conversely, Sarkisian's study showed a tendency towards lower IOP in the complete compared to the partial trabeculotomy subgroups. The small sample size of the two subgroups in both his and our studies, however, limits statistical comparison.
It is worth noting that the preoperative IOP was significantly higher in eyes in which the microcatheter could not be passed 360°around the limbus (p = 0.006). This may be an indicator of more advanced disease, possibly causing more compression of trabecular lamellae and Schlemm's canal.
Primary congenital glaucoma tends to be more advanced in the Middle East (Debnath et al. 1989; Al-Hazmi et al. 2005) , possibly because of genetic factors, the high rate of consanguinity and the delay in seeking medical care. This is the first study looking at the results of microcatheter-assisted trabeculotomy in Middle-Eastern eyes. Our success rates at 2 years were comparable to most previous studies, and only slightly lower than the 12-month results by Girkin et al. (2012b) . On the other hand, the success rate of conventional 180°trabeculotomy in our study was 50%, with 47% of eyes having a pressure of <18 mmHg on no medications at 2 years postoperatively. This is lower than some other studies on trabeculotomy, such as by Yalvac et al. (2007) who showed an 82% success rate at 2 years, with success defined as IOP <18 and more than 5 mmHg. However, our results are comparable to those by ElSheikha et al. (2015) who showed a 60% success rate of trabeculotomy in Egyptian eyes at 6 months, and Shi et al. (2015) who had 51.6% complete and 61.9% qualified success rates at 1 year, with success defined as an IOP of <21 mmHg. We prefer an inferotemporal approach when it comes to trabeculotomy as this leaves the superior conjunctiva relatively healthy, in case a trabeculectomy or shunt procedure is subsequently required. However, in some cases where the microcatheter course was interrupted requiring a scleral cut down, the site of the incision had to be placed superiorly. We speculate that this may have adverse effects on success of subsequent glaucoma procedures, because of the possible higher risk of conjunctival scarring.
We opted for Schlemm's canal deroofing in the microcatheter group as this improved our chances of accurately locating Schlemm's canal, excluding the presence of any perforation in its floor and easily sliding the microcatheter into its ends. However, we occasionally encountered cases that showed a localized conjunctival elevation overlying the scleral flap, possibly denoting a filtering bleb (Fig. 4) . The presence of such a bleb may have contributed to the occurrence of late endophthalmitis in one of the cases, especially because blebs located in the inferior fornix are known to be associated with a higher risk of infection (Soltau et al. 2000) .
Our study showed that eyes that underwent microcatheter-assisted trabeculotomy had a lower IOP compared to rigid probe trabeculotomy and a significantly lower chance of requiring a subsequent glaucoma procedure. Larger studies may be required to correlate the extent of trabeculotomy with IOP reduction.
